Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06356220 · ClinicalTrials.gov registry record · NA

GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)

A NA study of Celiac Disease in Children and Nutrition Disorder, Child, sponsored by Boston Children's Hospital.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06356220 is a NA study of Celiac Disease in Children and Nutrition Disorder, Child that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06356220, a NA study of Celiac Disease in Children and Nutrition Disorder, Child, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The investigators propose the Gluten Free Nutrition Optimization through Ultra-processed food Reduction and Improved Strategies for Health (GF-NOURISH) study to demonstrate the feasibility and success of a nutritional education program focused on naturally occurring gluten-free foods and minimizing ultra-processed gluten-free foods. The investigators hypothesize that nutritional educational (GF-NOURISH) intervention will have multiple health benefits

Interventions

  • OTHER Gluten-Free Diet Education

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-04-29
Est. Completion 2026-12
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT06356220

The ClinicalTrials.gov registry entry for NCT06356220 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Celiac Disease in Children appearing as the primary indexed condition, and to 1 intervention - of which Gluten-Free Diet Education is the first listed.

NCT06356220 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06356220 about?

NCT06356220 is a clinical study titled "GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)". The investigators propose the Gluten Free Nutrition Optimization through Ultra-processed food Reduction and Improved Strategies for Health (GF-NOURISH) study to demonstrate the feasibility and success of a nutritional education program focused on naturally occurring gluten-free foods and minimizing ...

What is the current status of trial NCT06356220?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-04-29. Estimated completion is 2026-12.

What conditions does trial NCT06356220 study?

This clinical trial studies the following conditions: Celiac Disease in Children, Nutrition Disorder, Child.

What interventions are being tested in trial NCT06356220?

The interventions under investigation include: Gluten-Free Diet Education (OTHER).

Who is sponsoring clinical trial NCT06356220?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06356220 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Celiac Disease in Children

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.